Laboratory Corp Of America Holdings
Research Laboratory Corp Of America Holdings (LH) on Bullrun: valuation model: 11.9% overvalued, market cap USD 27.32B, P/E 27.9, dividend yield 0.6%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerLH
- ExchangeNYSE
- CountryUnited States
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyUSD
- Valuation signal11.9% overvalued
- Market capUSD 27.32B
- P/E27.9
- Dividend yield0.6%
- Financial periodQ2 2026
- RevenueUSD 3.73B
- Net incomeUSD 298.70M
- Free cash flowUSD 313.90M
- Gross margin29.8%
Valuation Snapshot
Bullrun's latest valuation model marks Laboratory Corp Of America Holdings as 11.9% overvalued; latest market cap is USD 27.32B; P/E is 27.9; dividend yield is 0.6%.
Peer valuation comparison
Latest P/E is 27.92x versus a Healthcare sector median of 24.46x (14.2% above).
Latest dividend yield is 0.64% versus a Healthcare sector median of 2.11% (69.7% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 13.95B | USD 877.00M | USD 1.21B | 28.8% | 10.46 | USD 532.30M | USD 5.58B | USD 8.62B |
| FY2024 | USD 13.01B | USD 746.00M | USD 1.10B | 27.9% | 8.84 | USD 1.52B | USD 6.33B | USD 8.05B |
| FY2023 | USD 12.16B | USD 418.00M | USD 874.10M | 27.7% | 4.77 | USD 536.80M | USD 5.05B | USD 7.88B |
| FY2022 | USD 11.86B | USD 1.28B | USD 1.53B | 31.3% | 13.97 | USD 320.60M | USD 5.34B | USD 10.10B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 27.32B | 27.9 | 0.9% | 2.88 |
| 2025 | 2025-12-31 | USD 20.62B | 24.0 | 1.1% | 2.88 |
| 2024 | 2024-12-31 | USD 19.13B | 25.9 | 1.3% | 2.88 |
| 2023 | 2023-12-29 | USD 19.30B | 30.4 | 1.2% | 2.68 |
| 2022 | 2022-12-30 | USD 17.92B | 10.8 | 0.9% | 1.86 |
| 2021 | 2021-12-31 | USD 25.13B | 11.1 | n/a | n/a |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 2.88 USD, yield 0.6%.
| Year | Dividends/share |
|---|---|
| FY2025 | 2.88 USD |
| FY2024 | 2.88 USD |
| FY2023 | 2.88 USD |
| FY2022 | 2.16 USD |
About Laboratory Corp Of America Holdings
Labcorp Holdings Inc. provides laboratory services. It operates in Diagnostics Laboratories and Biopharma Laboratory Services segments. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C, PSA, tests for sexually transmitted diseases, vitamin D testing, microbiology cultures and procedures, and alcohol and other substance abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing;
Related stock research
Other Healthcare stocks
Frequently asked questions
Is Laboratory Corp Of America Holdings overvalued or undervalued?
Bullrun's valuation model currently marks Laboratory Corp Of America Holdings as 11.9% overvalued.
What is Laboratory Corp Of America Holdings's market cap?
Laboratory Corp Of America Holdings's market capitalization is USD 27.32B.
What is Laboratory Corp Of America Holdings's P/E ratio?
Laboratory Corp Of America Holdings's price-to-earnings (P/E) ratio is 27.9.
Does Laboratory Corp Of America Holdings pay a dividend?
Laboratory Corp Of America Holdings has a dividend yield of 0.6%.
What does Laboratory Corp Of America Holdings do?
Labcorp Holdings Inc. provides laboratory services. It operates in Diagnostics Laboratories and Biopharma Laboratory Services segments. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C, PSA, tests for sexually transmitted diseases, vitamin D testing, microbiology cultures and procedures, and alcohol and other substance abuse tests.